Discover

CDMO
Avid Bioservices, Inc.
12.49
undefined x undefined
undefined x undefined
bid
ask
+
0.00
0.00%
04:00 PM
Ytd1.13%
1y55.16%
12.49
day range
12.49
52 week range
Open12.49Prev Close12.49Low12.49High12.49Mkt CapN/A
Vol0.00Avg Vol0.00EPSN/AP/EN/AForward P/E-175.29
Beta1.41Short Ratio3.19Inst. Own104.32%DividendN/ADiv YieldN/A
Ex Div DateN/AEarningN/A50-d AvgN/A200-d AvgN/A1yr Est12.88
Earning
DateForEstimateReportedSurprisesurprise %
2024-12-102024-10-0.09-0.22-0.13-144.44%
2024-09-092024-07-0.04-0.030.0125.00%
2024-07-022024-040.03-0.07-0.1-333.33%
2024-04-242024-01-0.02-0.08-0.06-300.00%
2023-12-072023-10-0.09-0.12-0.03-33.33%
2023-09-072023-07-0.04N/AN/AN/A
Upgrade / Downgrade
DateFirmActionFromTo
2024-11-07RBC CapitalDowngradeOutperformSector Perform
2024-11-07William BlairUpgradeMarket Perform
2024-09-10RBC CapitalUpgradeOutperformOutperform
2024-09-10Stephens & Co.UpgradeOverweightOverweight
2024-09-10William BlairUpgradeMarket Perform
2024-07-03RBC CapitalUpgradeOutperformOutperform
Profile
Avid Bioservices, Inc. operates as a contract development and manufacturing organization for the biotechnology and biopharmaceutical industries in the United States. It provides process development and current good manufacturing practice clinical and commercial manufacturing services of biologics, including clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, regulatory submission and support, upstream and downstream development and optimization, analytical methods development, cell line development, testing, and characterization services. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is based in Tustin, California.
Insider Holder
DateNameRelationQuantityDescription
2024-12-12ALEGRIA ESTHER MDirector37.75KConversion of Exercise of derivative security
2024-12-12CARLEONE JOSEPHDirector130.32KConversion of Exercise of derivative security
2024-10-09GREEN NICHOLAS STEWARTChief Executive Officer226.65KSale
2024-12-12HANCOCK RICHARD BROOKEDirector144.32KConversion of Exercise of derivative security
2024-04-29HART DANIEL RYANChief Financial Officer82.22KSale
2024-10-13KWIETNIAK MATTHEW ROfficer25.41KSale
Institution Ownership
Report DateOrganizationPositionValuePercentage
2024-09-29Blackrock Inc.5.26M64.53M8.22%
2024-09-29Millennium Management Llc4.19M51.40M6.55%
2024-09-29Vanguard Group Inc3.85M47.20M6.01%
2024-09-29Point72 Asset Management, L.P.3.82M46.82M5.97%
2024-09-29AltraVue Capital, LLC3.80M46.60M5.94%
2024-09-29State Street Corporation3.00M36.84M4.69%
Fund Ownership
Report DateOrganizationPositionValuePercentage
2024-09-29Vanguard Total Stock Market Index Fund2.05M25.14M3.20%
2024-10-30iShares Russell 2000 ETF1.58M19.44M2.48%
2024-07-30Fidelity Strategic Advisors Small-Mid Cap Fund1.34M16.50M2.10%
2024-09-29SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF1.32M16.14M2.06%
2024-10-30Fidelity Rutland Square Tr II-Strategic Advisers U.S. Total Stock Fd1.13M13.81M1.76%
2024-09-29Vanguard Extended Market Index Fund988.82K12.13M1.55%
Dividend
DividendDate
0.662018-03-16
Split
SplitDate
1 : 72017-07-10
0.2 : 12009-10-19